Picture of Acadia Pharmaceuticals logo

ACAD Acadia Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapNeutral

Acadia Pharmaceuticals Inc Reports Results For The Quarter Ended In December: Earnings Summary

* ACADIA Pharmaceuticals Inc  ACAD.OQ  reported quarterly
adjusted
earnings of 28 cents​​ per share for the quarter ended in
December, higher than the same quarter last year, when the
company reported EPS of -26 cents.  The mean expectation of
twenty one analysts for the quarter was for earnings of 30 cents
per share. Wall Street expected results to range from 20 cents
to 59 cents per share.
    * Revenue rose 69.3% to $231.04 million from a year ago;
analysts
expected $223.79 million. 
    * ACADIA Pharmaceuticals Inc's reported EPS for the quarter
was 28
cents​.
    * The company reported quarterly net income of $45.8
million.
    * ACADIA Pharmaceuticals Inc shares had fallen by 17.3% this
quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 0.9%
in the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 15 "strong buy" or "buy," 5
"hold" and 1 "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for ACADIA
Pharmaceuticals Inc is $35.50 
This summary was machine generated from LSEG data February 27 at
11:19 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      0.30           0.28           Missed
 Sep. 30 2023      -0.43          -0.40          Beat
 Jun. 30 2023      -0.08          0.01           Beat
 Mar. 31 2023      -0.21          -0.27          Missed

Recent news on Acadia Pharmaceuticals

See all news